Copyright Reports & Markets. All rights reserved.

Global Extended Release Drug Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Extended Release Drug Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Extended Release Drug Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Sustained Release Drug
    • 1.4.3 Controlled Release Drug
  • 1.5 Market by Application
    • 1.5.1 Global Extended Release Drug Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital Pharmacy
    • 1.5.3 Retail Pharmacy
    • 1.5.4 Online Pharmacy
  • 1.6 Coronavirus Disease 2019 (Covid-19): Extended Release Drug Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Extended Release Drug Industry
      • 1.6.1.1 Extended Release Drug Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Extended Release Drug Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Extended Release Drug Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Extended Release Drug Market Perspective (2015-2026)
  • 2.2 Extended Release Drug Growth Trends by Regions
    • 2.2.1 Extended Release Drug Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Extended Release Drug Historic Market Share by Regions (2015-2020)
    • 2.2.3 Extended Release Drug Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Extended Release Drug Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Extended Release Drug Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Extended Release Drug Players by Market Size
    • 3.1.1 Global Top Extended Release Drug Players by Revenue (2015-2020)
    • 3.1.2 Global Extended Release Drug Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Extended Release Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Extended Release Drug Market Concentration Ratio
    • 3.2.1 Global Extended Release Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Extended Release Drug Revenue in 2019
  • 3.3 Extended Release Drug Key Players Head office and Area Served
  • 3.4 Key Players Extended Release Drug Product Solution and Service
  • 3.5 Date of Enter into Extended Release Drug Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Extended Release Drug Historic Market Size by Type (2015-2020)
  • 4.2 Global Extended Release Drug Forecasted Market Size by Type (2021-2026)

5 Extended Release Drug Breakdown Data by Application (2015-2026)

  • 5.1 Global Extended Release Drug Market Size by Application (2015-2020)
  • 5.2 Global Extended Release Drug Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Extended Release Drug Market Size (2015-2020)
  • 6.2 Extended Release Drug Key Players in North America (2019-2020)
  • 6.3 North America Extended Release Drug Market Size by Type (2015-2020)
  • 6.4 North America Extended Release Drug Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Extended Release Drug Market Size (2015-2020)
  • 7.2 Extended Release Drug Key Players in Europe (2019-2020)
  • 7.3 Europe Extended Release Drug Market Size by Type (2015-2020)
  • 7.4 Europe Extended Release Drug Market Size by Application (2015-2020)

8 Asia-Pacific

  • 8.1 Asia-Pacific Extended Release Drug Market Size (2015-2020)
  • 8.2 Extended Release Drug Key Players in Asia-Pacific (2019-2020)
  • 8.3 Asia-Pacific Extended Release Drug Market Size by Type (2015-2020)
  • 8.4 Asia-Pacific Extended Release Drug Market Size by Application (2015-2020)

(2015-2020)

    (2015-2020)

      9 Key Players Profiles

      • 9.1 Pfizer
        • 9.1.1 Pfizer Company Details
        • 9.1.2 Pfizer Business Overview and Its Total Revenue
        • 9.1.3 Pfizer Extended Release Drug Introduction
        • 9.1.4 Pfizer Revenue in Extended Release Drug Business (2015-2020))
        • 9.1.5 Pfizer Recent Development
      • 9.2 Mallinckrodt
        • 9.2.1 Mallinckrodt Company Details
        • 9.2.2 Mallinckrodt Business Overview and Its Total Revenue
        • 9.2.3 Mallinckrodt Extended Release Drug Introduction
        • 9.2.4 Mallinckrodt Revenue in Extended Release Drug Business (2015-2020)
        • 9.2.5 Mallinckrodt Recent Development
      • 9.3 Teva
        • 9.3.1 Teva Company Details
        • 9.3.2 Teva Business Overview and Its Total Revenue
        • 9.3.3 Teva Extended Release Drug Introduction
        • 9.3.4 Teva Revenue in Extended Release Drug Business (2015-2020)
        • 9.3.5 Teva Recent Development
      • 9.4 Johnson & Johnson
        • 9.4.1 Johnson & Johnson Company Details
        • 9.4.2 Johnson & Johnson Business Overview and Its Total Revenue
        • 9.4.3 Johnson & Johnson Extended Release Drug Introduction
        • 9.4.4 Johnson & Johnson Revenue in Extended Release Drug Business (2015-2020)
        • 9.4.5 Johnson & Johnson Recent Development
      • 9.5 Endo Pharmaceuticals
        • 9.5.1 Endo Pharmaceuticals Company Details
        • 9.5.2 Endo Pharmaceuticals Business Overview and Its Total Revenue
        • 9.5.3 Endo Pharmaceuticals Extended Release Drug Introduction
        • 9.5.4 Endo Pharmaceuticals Revenue in Extended Release Drug Business (2015-2020)
        • 9.5.5 Endo Pharmaceuticals Recent Development
      • 9.6 Purdue Pharma
        • 9.6.1 Purdue Pharma Company Details
        • 9.6.2 Purdue Pharma Business Overview and Its Total Revenue
        • 9.6.3 Purdue Pharma Extended Release Drug Introduction
        • 9.6.4 Purdue Pharma Revenue in Extended Release Drug Business (2015-2020)
        • 9.6.5 Purdue Pharma Recent Development
      • 9.7 Mylan
        • 9.7.1 Mylan Company Details
        • 9.7.2 Mylan Business Overview and Its Total Revenue
        • 9.7.3 Mylan Extended Release Drug Introduction
        • 9.7.4 Mylan Revenue in Extended Release Drug Business (2015-2020)
        • 9.7.5 Mylan Recent Development
      • 9.8 Hisamitsu Pharmaceutical
        • 9.8.1 Hisamitsu Pharmaceutical Company Details
        • 9.8.2 Hisamitsu Pharmaceutical Business Overview and Its Total Revenue
        • 9.8.3 Hisamitsu Pharmaceutical Extended Release Drug Introduction
        • 9.8.4 Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2015-2020)
        • 9.8.5 Hisamitsu Pharmaceutical Recent Development
      • 9.9 Sun Pharmaceutical Industries
        • 9.9.1 Sun Pharmaceutical Industries Company Details
        • 9.9.2 Sun Pharmaceutical Industries Business Overview and Its Total Revenue
        • 9.9.3 Sun Pharmaceutical Industries Extended Release Drug Introduction
        • 9.9.4 Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2015-2020)
        • 9.9.5 Sun Pharmaceutical Industries Recent Development

      10 Analyst's Viewpoints/Conclusions

        11 Appendix

        • 11.1 Research Methodology
          • 11.1.1 Methodology/Research Approach
          • 11.1.2 Data Source
        • 11.2 Disclaimer

        This report focuses on the global Extended Release Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Extended Release Drug development in North America, Europe and Asia-Pacific.

        The key players covered in this study
        Pfizer
        Mallinckrodt
        Teva
        Johnson & Johnson
        Endo Pharmaceuticals
        Purdue Pharma
        Mylan
        Hisamitsu Pharmaceutical
        Sun Pharmaceutical Industries

        Market segment by Type, the product can be split into
        Sustained Release Drug
        Controlled Release Drug
        Market segment by Application, split into
        Hospital Pharmacy
        Retail Pharmacy
        Online Pharmacy

        Market segment by Regions/Countries, this report covers
        North America
        Europe
        Asia-Pacific

        The study objectives of this report are:
        To analyze global Extended Release Drug status, future forecast, growth opportunity, key market and key players.
        To present the Extended Release Drug development in North America, Europe and Asia-Pacific.
        To strategically profile the key players and comprehensively analyze their development plan and strategies.
        To define, describe and forecast the market by type, market and key regions.

        In this study, the years considered to estimate the market size of Extended Release Drug are as follows:
        History Year: 2015-2019
        Base Year: 2019
        Estimated Year: 2020
        Forecast Year 2020 to 2026
        For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

        Buy now